Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
Launched by MINNEAPOLIS VETERANS AFFAIRS MEDICAL CENTER · Nov 2, 1999
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meets criteria for alcohol use disorder and other drug dependence.
- • Complete first week of alcohol treatment program.
- • Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).
- Exclusion Criteria:
- • Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder, schizophrenia or other psychotic disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating disorder, post- traumatic stress disorder, antisocial personality disorder, or borderline personality disorder.
- • Unable to participate in protocol due to functional deficits or severe depression.
- • Suicidal or homicidal ideation.
- • Current use of disulfiram (Antabuse) or naltrexone (Revia).
- • Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.
- • Lives more than 100 miles from alcohol treatment facility.
- • No telephone.
About Minneapolis Veterans Affairs Medical Center
The Minneapolis Veterans Affairs Medical Center (MVAMC) is a leading clinical research institution dedicated to advancing healthcare for veterans through innovative research and clinical trials. As a part of the Department of Veterans Affairs, MVAMC focuses on improving treatment outcomes and enhancing the quality of life for veterans by conducting rigorous scientific studies across various medical disciplines. With a commitment to ethical standards and patient-centered care, the center collaborates with multidisciplinary teams to explore new therapies, interventions, and technologies that address the unique health needs of the veteran population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials